A carregar...
Discovery and Characterization of Carbamothioylacrylamides As EP2 Selective Antagonists
[Image: see text] Prostanoid receptor EP2 is emerging as a novel target for development of anti-inflammatory drugs for the treatment of chronic neurodegenerative and peripheral diseases; however, the availability of EP2 antagonist probes for exploration of peripheral disease models is very limited....
Na minha lista:
| Main Authors: | , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
American Chemical Society
2013
|
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3731160/ https://ncbi.nlm.nih.gov/pubmed/23914286 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/ml400112h |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|